Characteristic | 69 patients |
---|---|
Age (year), mean ± SD | 57 ± 15 |
Gender, male, n (%) | 44(64) |
Immunocompromised status, n (%) | |
Hematologic malignancy | 23(33) |
Solid-organ transplantation | 14(20) |
Solid tumour receiving chemotherapy | 5(7) |
Immunosuppressive therapya | 21(30) |
Prolonged corticosteroid therapyb | 33(48) |
Disease severity | |
PSI score, mean ± SD | 127 ± 51 |
Invasive mechanical ventilation, n (%) | 22(32) |
Septic shock, n (%) | 25(36) |
Laboratory findings | |
WBC (109/L), median (Q1, Q3) | 6.58(4.93,11.05) |
Neutrophils (109/L), median (Q1, Q3) | 5.66(3.23,9.39) |
Lymphocyte count (106/L), median (Q1, Q3) | 0.73(0.35,1.17) |
PaO2/FiO2, mean ± SD | 196 ± 98 |
Albumin (g/L), mean ± SD | 30 ± 7 |
Serum creatinine(mmol/L), median (Q1, Q3) | 80(57, 127) |
LDH (U/L), median (Q1, Q3) | 432(304, 726) |
CRP (mg/l), median (Q1, Q3) | 88(42,149) |
PCT (ng/ml), median (Q1, Q3) | 0.27(0.11,1.20) |
outcome | |
Total 30-day mortality, n (%) | 14(20) |